Dr Reddy's buys UCB portfolio in S Asia

 
• By Anju Ghangurde

Dr Reddy's Laboratories has snapped up a select portfolio of UCB's established products business in India, Nepal, Sri Lanka and Maldives for INR8bn ($128m), bolstering its presence in the high growth dermatology, respiratory and paediatric segments.

More from Focus On Asia

More from Scrip